United Kingdom · Mental health care startup

Mettle

Mettle, also known as Head Shed, is a UK-registered company that focuses on enhancing men's mental fitness.

Funding reportedLast round: Seed

Mental health careLondon, United Kingdom

About Mettle

Mettle, also known as Head Shed, is a UK-registered company that focuses on enhancing men's mental fitness.

It offers online and mobile programs that include guided meditation, mind-hacking techniques, and breathwork exercises. These programs are designed for ambitious men who seek to balance their success with overall wellbeing. The company's mission is to provide science-backed tools that help reduce anxiety, manage stress, and improve sleep. Mettle's structured programs are tailored to meet the needs of high-performing individuals, emphasizing practical strategies for mental health. The services are accessible through a website and mobile app, making it easy for users to engage with the content.

What company datasets say Mettle raised

Funding, as reported

Reported in all2.5Min the source's currency
Rounds1
Last roundSeed
Last round size3.3M
Last round dateNov 2023
Investors listed3

The company, in detail

What they build

Known for

mobile appsself-confidencemotivation techniquesfocus enhancementmental resiliencesleep improvementsleep hygieneinformation technology & servicesmen's mental healthanxiety managementstress reliefscience-backedconfidence boostingmen's healthmental health appmental health

Built with from their website

Google Tag ManagerApacheMailChimpGoogle WorkspaceViewport MetaGoogle PlayGoogle AnalyticsGoDaddy DomainsGoogle Analytics 4Amazon AWS

+8 more

Mailchimp MandrillGoogle MeetGoogle Font APICookiebotApache HTTP ServerMobile FriendlyGoDaddy HostingOpen Graph

Sector
Mental health care
Industry code
NAICS 61142, 62133, SIC 8734
Region
England
Full record
Every detail in the company directory

Mental health care in United Kingdom

Startups like it

Is this your company?

Add your raise, your deck and your story, and put Mettle in front of investors. Or tell us what we have wrong.